A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer
Shanghai Yunying Medical Technology
Shanghai Yunying Medical Technology
SpeciCare
National Cancer Institute (NCI)
National Cancer Institute (NCI)